🇺🇸 FDA
Patent

US 11591369

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

granted A61KA61K38/00A61K45/06

Quick answer

US patent 11591369 (Alpha(v)beta(6) integrin-binding peptides and methods of use thereof) held by The Regents of the University of California expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K38/00, A61K45/06, A61K47/60, A61K51/08